Preoperative risk score to predict subtotal cholecystectomy after gallbladder drainage for acute cholecystitis: Secondary analysis of data from a multi-institutional retrospective study (CSGO-HBP-017B).


Journal

Asian journal of endoscopic surgery
ISSN: 1758-5910
Titre abrégé: Asian J Endosc Surg
Pays: Japan
ID NLM: 101506753

Informations de publication

Date de publication:
Jul 2022
Historique:
revised: 14 02 2022
received: 17 01 2022
accepted: 19 02 2022
pubmed: 19 3 2022
medline: 7 7 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

Subtotal cholecystectomy (STC) has become recognized as a "bailout procedure" to prevent bile duct injury in patients undergoing laparoscopic cholecystectomy (LC). Predictors of conversion to STC have not been identified because LC difficulty varies based on pericholecystic inflammation. We analyzed data from patients enrolled in a previously performed multi-institutional retrospective study of the optimal timing of LC after gallbladder drainage for acute cholecystitis (AC). These patients presumably had a considerable degree of pericholecystic inflammation. In total, 347 patients who underwent LC after gallbladder drainage for AC were analyzed to examine preoperative and perioperative factors predicting conversion to STC. Three hundred patients underwent total cholecystectomy (TC) and 47 underwent conversion to STC. Eastern Cooperative Oncology Group Performance Status (ECOG PS) (P < .01), severity of cholecystitis (P = .04), previous history of treatment for common bile duct stones (CBDS) (P < .01), and surgeon experience (P = .03) were significantly associated with conversion to STC. Logistic regression analyses showed that ECOG PS (odds ratio 0.2; P < .0001) and previous history of treatment for CBDS (odds ratio 0.37; P = .0073) were independent predictors of conversion to STC. Our predictive risk score using these two variables suggested that a score ≥2 could discriminate between TC and STC (P < .0001). Poor ECOG PS and previous history of treatment for CBDS were significantly associated with conversion to STC after gallbladder drainage for AC.

Identifiants

pubmed: 35302288
doi: 10.1111/ases.13051
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-562

Informations de copyright

© 2022 Asia Endosurgery Task Force and Japan Society of Endoscopic Surgery and John Wiley & Sons Australia, Ltd.

Références

Pucher PH, Brunt LM, Davies N, et al. Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: a systematic review and pooled data analysis. Surg Endosc. 2018;32(5):2175-2183.
Strasberg SM, Brunt LM. Rationale and use of the critical view of safety in laparoscopic cholecystectomy. J Am Coll Surg. 2010;211(1):132-138.
Hugh TB. New strategies to prevent laparoscopic bile duct injury--surgeons can learn from pilots. Surgery. 2002;132(5):826-835.
Lunevicius R. Laparoscopic subtotal cholecystectomy: a classification, which encompasses the variants, technical modalities, and extent of resection of the gallbladder. Ann R Coll Surg Engl. 2020;102(4):315-317.
Sabour AF, Matsushima K, Love BE, et al. Nationwide trends in the use of subtotal cholecystectomy for acute cholecystitis. Surgery. 2020;167(3):569-574.
Santos BF, Brunt LM, Pucci MJ. The difficult gallbladder: a safe approach to a dangerous problem. J Laparoendosc Adv Surg Tech A. 2017;27(6):571-578.
Chávez-Villa M, Dominguez-Rosado I, Figueroa-Méndez R, De Los Santos-Pérez A, Mercado MA. Subtotal cholecystectomy after failed critical view of safety is an effective and safe bail out strategy. J Gastrointest Surg. 2021;25(10):2553-2561.
Hartnett DA, Eltorai AEM, Osband AJ, Ahmed SA, Daniels AH. Cholecystectomy-related malpractice litigation: predictive factors of case outcome. Updates Surg. 2019;71(3):463-469.
Nzenwa IC, Mesri M, Lunevicius R. Risks associated with subtotal cholecystectomy and the factors influencing them: a systematic review and meta-analysis of 85 studies published between 1985 and 2020. Surgery. 2021;170(4):1014-1023.
Tang A, Cohan CM, Beattie G, Mooney CM, Chiang A, Keeley JA. Factors that predict the need for subtotal cholecystectomy. Am Surg. 2021;87(8):1245-1251.
Kohga A, Suzuki K, Okumura T, et al. Does preoperative MRCP imaging predict risk for conversion to subtotal cholecystectomy in patients with acute cholecystitis? Surg Endosc. 2021;35(12):6717-6723.
Tomimaru Y, Fukuchi N, Yokoyama S, et al. Optimal timing of laparoscopic cholecystectomy after gallbladder drainage for acute cholecystitis: a multi-institutional retrospective study. J Hepatobiliary Pancreat Sci. 2020;27(8):451-460.
Miura F, Takada T, Strasberg SM, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):47-54.
Miura F, Takada T, Kawarada Y, et al. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Sci. 2007;14(1):27-34.
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649-655.
Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49(4):239-243.
Hackett NJ, De Oliveira GS, Jain UK, Kim JY. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184-190.
Glance LG, Lustik SJ, Hannan EL, et al. The surgical mortality probability model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012;255(4):696-702.
Panda N, Chang Y, Chokengarmwong N, et al. Gallstone pancreatitis and Choledocholithiasis: using imaging and laboratory trends to predict the likelihood of persistent stones at cholangiography. World J Surg. 2018;42(10):3143-3149.
Palermo M, Fendrich I, Ronchi A, Obeid J, Gimenez M. Laparoscopic common bile duct exploration using a single-operator Cholangioscope. J Laparoendosc Adv Surg Tech A. 2020;30(9):989-992.
Al-Temimi MH, Trujillo C, Shah M, et al. Same-day versus conventional different-day endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy: a multi-center retrospective study. Am Surg. 2018;84(10):1679-1683.
Gao MJ, Jiang ZL. Effects of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography on liver, bile, and inflammatory indices and cholecysto-choledocholithiasis patient prognoses. Clinics (Sao Paulo). 2021;76:e2189.
Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781-1788.
Vitte RL, Morfoisse JJ. Evaluation of endoscopic retrograde cholangiopancreatography procedures performed in general hospitals in France. Gastroenterol Clin Biol. 2007;31(8-9 Pt 1):740-749.
da Costa DW, Schepers NJ, Bouwense SA, et al. Predicting a 'difficult cholecystectomy' after mild gallstone pancreatitis. HPB (Oxford). 2019;21(7):827-833.
Ishizaki Y, Miwa K, Yoshimoto J, Sugo H, Kawasaki S. Conversion of elective laparoscopic to open cholecystectomy between 1993 and 2004. Br J Surg. 2006;93(8):987-991.
Elshaer M, Gravante G, Thomas K, Sorge R, Al-Hamali S, Ebdewi H. Subtotal cholecystectomy for "difficult gallbladders": systematic review and meta-analysis. JAMA Surg. 2015;150(2):159-168.
Henneman D, da Costa DW, Vrouenraets BC, van Wagensveld BA, Lagarde SM. Laparoscopic partial cholecystectomy for the difficult gallbladder: a systematic review. Surg Endosc. 2013;27(2):351-358.
Ahmad F, Saunders RN, Lloyd GM, Lloyd DM, Robertson GS. An algorithm for the management of bile leak following laparoscopic cholecystectomy. Ann R Coll Surg Engl. 2007;89(1):51-56.
Mesri M, Nzenwa IC, Lunevicius R. Evaluating the patient and setting-specific factors that influenced the quality of informed consent in a retrospective cohort of subtotal cholecystectomy patients. J Laparoendosc Adv Surg Tech A. 2021;31(1):77-84.
Zhao J, Fan Y, Wu S. Safety and feasibility of laparoscopic approaches for the management of Mirizzi syndrome: a systematic review. Surg Endosc. 2020;34(11):4717-4726.

Auteurs

Hideo Tomihara (H)

Department of Surgery, Faculty of Medicine, Nara Hospital, Kindai University, Ikoma, Japan.
Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.

Yoshito Tomimaru (Y)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Toyonaka Municipal Hospital, Toyonaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Kazuhiko Hashimoto (K)

Department of Surgery, Faculty of Medicine, Nara Hospital, Kindai University, Ikoma, Japan.
Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.

Nariaki Fukuchi (N)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Suita Municipal Hospital, Suita, Japan.

Shigekazu Yokoyama (S)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Japan.

Takuji Mori (T)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Tane General Hospital, Osaka, Japan.

Masahiro Tanemura (M)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Osaka Police Hospital, Osaka, Japan.
Department of Surgery, Rinku General Medical Center, Osaka, Japan.

Kenji Sakai (K)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Japan Community Health Care Organization, Osaka Hospital, Osaka, Japan.

Yutaka Takeda (Y)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan.

Masanori Tsujie (M)

Department of Surgery, Faculty of Medicine, Nara Hospital, Kindai University, Ikoma, Japan.
Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Osaka Rosai Hospital, Sakai, Japan.

Terumasa Yamada (T)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan.

Atsushi Miyamoto (A)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Department of Surgery, Sakai City Medical Center, Sakai, Japan.

Yasuji Hashimoto (Y)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Yao Municipal Hospital, Yao, Japan.

Hisanori Hatano (H)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Osaka Police Hospital, Osaka, Japan.
Department of Surgery, Ashiya Municipal Hospital, Ashiya, Japan.

Junzo Shimizu (J)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Toyonaka Municipal Hospital, Toyonaka, Japan.
Department of Surgery, Osaka Rosai Hospital, Sakai, Japan.

Keishi Sugimoto (K)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Minoh City Hospital, Minoh, Japan.
Department of Surgery, Kawanishi City Hospital, Kawanishi, Japan.

Masaki Kashiwazaki (M)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Surgery, Osaka General Medical Center, Osaka, Japan.
Department of Surgery, Otemae Hospital, Osaka, Japan.

Kenichi Matsumoto (K)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Shogo Kobayashi (S)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Yuichiro Doki (Y)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Hidetoshi Eguchi (H)

Hepato-Biliary-Pancreatic Group, Clinical Study Group of Osaka University, Osaka, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH